were receiving medication known to interfere with endocrine function were omitted, as were two patients with evi-
Disturbances in male sex hormones have been recently reported in male epileptic patients on anticonvulsant drugs. Christiansen et all were the first to observe diminished excretion of androsterone and dehydroepiandosterone compared with normal controls. The same group2 studied endocrine change after three months of treatment with either phenytoin or carbamazepine. They confirmed the reduced excretion of androgens, but noted an increase in the serum concentration of testosterone in patients on phenytoin. An (table 2) . Other hormonal measures failed to discriminate, but both TT (t = 2-04; p<0-05) and PRL (t = 2-02; p<0-05) were increased in the high drive group using frequency of sexual activity as the behavioural variable. Plasma anticonvulsant levels were correlated with sexual behaviour measures, but no relationship could be detected.
Discussion
In an earlier study,4 we reported raised TT, SHBG and LH in a group of male epileptic patients attending an out-patient department. Sexual activity also appeared reduced, and taking these findings in conjunction, a diminution in FT was predicted. This has recently been reported5 and our present data provide further confirmation. In the earlier report we The nature of the study imposed certain methodological constraints. The resident population of the David Lewis Centre is of less than average intelligence and level of educational attainment; they had led relatively sheltered lives. For this reason it was necessary to construct an ad hoc interview schedule rather than use one of the more established methods of enquiry. With respect to the behavioural variables, it was not possible to identify an appropriate control group; such a group should also have been institutionalised, brain-damaged but not epileptic.
There are several possible explanations for the hormonal findings. A fall in plasma testosterone (both free and bound) due to increased metabolism, or, less probably, impaired testicular synthesis leads firstly to a rise in LH with consequent increase in testosterone synthesis and so to an increase in bound testosterone and FT; and secondly to a rise in SHBG, which in turn leads to a further increase in bound testosterone and to a fall in FT. Alternatively, anticonvulsant drugs may induce SHBG directly. A rise in SHBG levels in female patients on phenytoin has been reported," and its possible use as an index of liver enzyme induction suggested. However, this argument would benefit if sex hormone changes could be related to some index of liver enzyme induction independent of sex hormone metabolism. A drug induced rise in PRL may be the prime mover. An increase in PRL levels leads to a fall in FT and sexual impotence. Both can be reversed by bromocryptine. A final explanation postulates a primary rise in oestrogens leading to an increase in SHBG.
Some other findings require comment. In two earlier studies3'4 TT and SHBG were markedly raised. Dana-Haeri et all confirmed the rise in SHBG but not in TT. In the present study, TT and SHBG were raised but less so than previously.6 In contrast, the increase in FSH, noted in the original study, was more pronounced. These differences may be related to chronicicity of treatment. The two earlier studies were carried out on outpatient populations; this study and to some extent that by Dana- Haeri et al,5 were based on residential populations in epilepsy centres, with a longer history of exposure to anticonvulsant drugs. Long-term treatment may lead to testicular failure, inability to respond to raised levels of LH, falling testosterone, and eventually, as reported by Christiansen et al,' impaired spermatogenesis. DHT values were found in this study to be higher in the epilepsy than in the control Toone, Wheeler, Nanjee, Fenwick, Grant group. This was contrary to expectations and may be explained by the fact that DHT has a greater affinity than FT for SHBG and may consequently be more slowly metabolised.
Christiansen et al' reported an association between impaired potency and reduced urinary excretion of androgens in 98 male epileptics. Our data confirm and extend these findings. We were again unable to establish a clear relationship between plasma levels of individual anticonvulsants and either hormonal or behavioural changes. The exception was sodium valproate, but the pattern of correlations was hard to interpret.
